News

Patient update

Policy regarding GLP-1 (glucagon-like peptide-1) weight management medication (tirzepatide, brand name Mounjaro) in Lancashire and South Cumbria

NHS Lancashire and South Cumbria has approved its policy regarding the prescription of tirzepatide (Mounjaro).

Patients are requested not to contact their GP practice as they will be contacted if eligible. 

The eligibility criteria has been determined as follows:

• Live in an area identified as one of the most deprived based on the Government’s indices of multiple deprivation (IMD-1).
• Have a body mass index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)

And have at least four of the following long-term conditions:

• Non-diabetic hyperglycaemia or type two diabetes
• Hypertension (high blood pressure)
• Dyslipidaemia
• Established cardiovascular disease
• Obstructive sleep apnoea (formally diagnosed)

NHS Primary Care Patient Safety Strategy

Find out about the Implementation of the NHS patient safety strategy in primary care

You and Your General Practice

NHS England » You and your general practice – English

GP Patient Survey Results

Find out how patients feel about their experiences with the surgery. 

GP Patient Survey